Session Information
2009 BIO International Convention
Click here to go to the previous page
Global Collaboration Structures to Sustain Viable Research-based Biomed Industry
Track : Global Biotechnology Issues
Program Code: 2778
Date: Tuesday, May 19, 2009
Time: 8:00 AM to 9:30 AM  EST
Location: B312
SPEAKER (S):
Zafrira Avnur, PhD, Roche
Steven Burrill, Burrill & Company
Daphna Heffetz, PhD, TransPharma Medical Ltd
Eli Opper, PhD, Ministry of Industry and Trade
Viren Sarin, PhD, Eli Lilly & Company
Yael Weiss, MD, Merck & Co, Inc
Description
Initiating, creating and maintaining successful alliances is one of the major challenges of the Life Sciences Industry worldwide, regardless of geographical location. A diverse group from governments, investors, Pharma and Biomed companies will share their experience and advice: What impact, advantages and risks, does the convergence of abilities and cross-border collaborations have on value creation and innovation potential for both partners? What models exist for partnering across geographic borders?

• Discuss new modes for cross-border collaborations as a source of innovation, capital and productivity
• Discuss the growth and development options for both Pharma and Biotech companies across geographical barriers
• Share key learning and advice by leading experts


Audio Synchronized to PowerPoint
(Code: 2778)
  
This session is a part of: